Wei Z. Deng

Guangzhou, 510405, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Corrigendum to "Dihydrobaicalein suppresses osteoclast differentiation and mitochondrial transfer to prevent postmenopausal osteoporosis" [Phytomedicine Volume 159, September 2026, 158564].

Corrigendum to "Dihydrobaicalein suppresses osteoclast differentiation and mitochondrial transfer to prevent postmenopausal osteoporosis" [Phytomedicine Volume 159, September 2026, 158564].

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 19, 2026

Molecular mechanism of intervertebral disc cell senescence: telomeres, mitochondria, and cellular metabolic reprogramming

Molecular mechanism of intervertebral disc cell senescence: telomeres, mitochondria, and cellular metabolic reprogramming

Journal: Sheng li xue bao : [Acta physiologica Sinica]

Published: June 26, 2026

Mitochondrial transfer-mediated metabolic reprogramming and drug resistance in bone metastasis: mechanisms and therapeutic strategies.

Mitochondrial transfer-mediated metabolic reprogramming and drug resistance in bone metastasis: mechanisms and therapeutic strategies.

Journal: Frontiers in immunology

Published: April 23, 2026

Dihydrobaicalein suppresses osteoclast differentiation and mitochondrial transfer to prevent postmenopausal osteoporosis.

Dihydrobaicalein suppresses osteoclast differentiation and mitochondrial transfer to prevent postmenopausal osteoporosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 24, 2026

Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.

Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.

Journal: Cancer metastasis reviews

Published: February 26, 2026

ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer.

ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer.

Journal: Molecular cancer

Published: January 17, 2026

Isonardosinone suppresses osteoclastogenesis through TRAF2/TRAF6-mediated disruption of calcium signaling and coordinate inhibition of MAPK/NF-κB pathways.

Isonardosinone suppresses osteoclastogenesis through TRAF2/TRAF6-mediated disruption of calcium signaling and coordinate inhibition of MAPK/NF-κB pathways.

Journal: BBA advances

Published: December 01, 2025

Fu Fang Sheng Mai capsules inhibit osteoclast formation and improve osteoporosis caused by oophorectomy in mice.

Fu Fang Sheng Mai capsules inhibit osteoclast formation and improve osteoporosis caused by oophorectomy in mice.

Journal: Fitoterapia

Published: October 26, 2025

Liquiritigenin suppresses osteoclastogenesis via multi-target mechanisms involving NF-κB/PI3K-AKT signaling pathways and metabolic reprogramming.

Liquiritigenin suppresses osteoclastogenesis via multi-target mechanisms involving NF-κB/PI3K-AKT signaling pathways and metabolic reprogramming.

Journal: Biochemical pharmacology

Published: October 11, 2025

Hijacking the bone niche: mechanistic insights into bone metastasis in breast cancer.

Hijacking the bone niche: mechanistic insights into bone metastasis in breast cancer.

Journal: Bone research

Published: August 25, 2025

A selective RCC1 inhibitor loaded in membrane-coated DNA nanocage for targeted suppression of TNBC progression.

A selective RCC1 inhibitor loaded in membrane-coated DNA nanocage for targeted suppression of TNBC progression.

Journal: Materials today. Bio

Published: July 05, 2025

A polymeric nanovesicle delivers sulfopin and gemcitabine to remodel tumor microenvironment for enhanced chemoimmunotherapy against orthotopic pancreatic cancer.

A polymeric nanovesicle delivers sulfopin and gemcitabine to remodel tumor microenvironment for enhanced chemoimmunotherapy against orthotopic pancreatic cancer.

Journal: Materials today. Bio

Published: March 12, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026